{"Adverse Reaction Reports": 28, "Company": "MODERNA", "Deaths": 0, "Disabilities": 0, "Hospitalizations": 0, "Life-Threatening Illnesses": 0, "batchcode": "3043822", "histogram": {"Abdominal pain": 1, "Abdominal pain upper": 3, "Arthralgia": 5, "Asthenia": 2, "Back pain": 1, "Biopsy": 1, "Blepharospasm": 1, "Blood test": 1, "Body temperature": 2, "Chest pain": 1, "Chills": 6, "Constipation": 1, "Cough": 1, "Decreased appetite": 2, "Diarrhoea": 1, "Discomfort": 1, "Dizziness": 6, "Dyspnoea": 2, "Dysstasia": 1, "Echocardiogram": 1, "Echocardiogram normal": 1, "Electric shock sensation": 1, "Electrocardiogram abnormal": 1, "Electrocardiogram ambulatory abnormal": 1, "Electrocardiogram normal": 1, "Erythema": 3, "Extrasystoles": 1, "Fatigue": 2, "Flushing": 1, "Gait disturbance": 1, "Headache": 6, "Hyperhidrosis": 1, "Hypokinesia": 1, "Injected limb mobility decreased": 1, "Injection site bruising": 2, "Injection site discolouration": 1, "Injection site erythema": 2, "Injection site pain": 2, "Injection site reaction": 2, "Injection site swelling": 1, "Injection site warmth": 1, "Intermenstrual bleeding": 1, "Lichen planus": 1, "Limb injury": 1, "Loss of consciousness": 1, "Loss of personal independence in daily activities": 1, "Lymph node pain": 1, "Malaise": 3, "Migraine": 1, "Muscular weakness": 1, "Musculoskeletal stiffness": 2, "Myalgia": 2, "Nausea": 2, "Neck pain": 1, "Night sweats": 2, "Oropharyngeal pain": 2, "Pain": 7, "Pain in extremity": 3, "Palpitations": 2, "Paraesthesia": 1, "Paranasal sinus hypersecretion": 1, "Peripheral swelling": 1, "Polymenorrhoea": 1, "Posture abnormal": 1, "Product administered to patient of inappropriate age": 1, "Pruritus": 1, "Pyrexia": 3, "Reaction to previous exposure to any vaccine": 1, "SARS-CoV-2 test negative": 1, "Sinus pain": 1, "Sleep disorder": 2, "Supraventricular extrasystoles": 1, "Syncope": 1, "Tenderness": 1, "Tinnitus": 1, "Tremor": 1, "Ultrasound Doppler normal": 1, "Unresponsive to stimuli": 1, "Urticaria": 1, "Vein disorder": 1, "Vomiting": 1, "Wrong technique in product usage process": 1}}